login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
XORTX THERAPEUTICS INC (XRTX.CA) Stock News
Canada
- TSX-V:XRTX -
CA98420Q3061
-
Common Stock
1.23
CAD
+0.01 (+0.82%)
Last: 10/15/2025, 7:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
XRTX.CA Latest News, Press Relases and Analysis
All
Press Releases
a month ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10
a month ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Initiates IND Preparation for XORLO™ in Gout Program
2 months ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Completes USD $114,500 Private Placement
3 months ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Completes Non-Brokered Private Placement of Units
4 months ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces USD $925,000 Private Placement
5 months ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces USD $3 Million Offering
9 months ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX to Present at Microcap Conference
9 months ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces Change of Auditor
10 months ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Strengthens Executive Team
6 months ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
7 months ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces Update for Discussion with the FDA
8 months ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Commences Gout Program NDA Discussions with the FDA
10 months ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces Presentation at the Rare and Genetic Disease Summit
a year ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
a year ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
2 years ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces US ATM Offering
2 years ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces Share Consolidation
a year ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Initiates Precision Medicine Program
a year ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces Results of Annual and Special Meeting of Shareholders
a year ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A
a year ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders
a year ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders
a year ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism
a year ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders
a year ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024
a year ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX to Present at BIO International Convention 2024
a year ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO
a year ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Reprices Warrants Issued in Connection with Previous Private Placements
1 years ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces Publication of Key Research in ADPKD
2 years ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Welcomes New Member to the Board of Directors
2 years ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces New Clinical Advisory Board Member
2 years ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial
2 years ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units
2 years ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units
2 years ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces $2 Million Public Offering
2 years ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease
2 years ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Welcomes New Member to the Board of Directors
2 years ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Meets Nasdaq Continued Listing Requirements
2 years ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Clarifies Timing for Share Consolidation
2 years ago - By: XORTX Therapeutics Inc.
- Mentions:
XRTX
XORTX Announces Results of Special Meeting of Shareholders
Please enable JavaScript to continue using this application.